0001127602-24-006234.txt : 20240221 0001127602-24-006234.hdr.sgml : 20240221 20240221215742 ACCESSION NUMBER: 0001127602-24-006234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tu Thomas CENTRAL INDEX KEY: 0001806426 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 24662128 MAIL ADDRESS: STREET 1: C/O INARI MEDICAL, INC. STREET 2: 9 PARKER AVENUE, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-16 0001531048 Inari Medical, Inc. NARI 0001806426 Tu Thomas C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 Chief Medical Officer 0 Common Stock 2024-02-16 4 A 0 14812 0 A 334016 D Stock Options (Right to Buy) 58.44 2024-02-16 4 A 0 16231 58.44 A 2031-02-15 Common Stock 16231 16231 D Represents annual restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2024 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. Includes 55 shares acquired on January 31, 2024 under the Company's Employee Stock Purchase Plan. Represents options to purchase shares of Issuer common stock which were granted on February 16, 2024 under the Issuer's 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis, with the first tranche vesting on April 1, 2024. /s/ Shannon Trevino, attorney-in-fact for Thomas Tu 2024-02-21